AXSM

Axsome Therapeutics News

Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
$80.29
Small Cap Basic
Monthly Subscription
for only
$33.03
Big Cap Pro
Monthly Subscription
for only
$52.04
VAT not included
Company Name Stock Ticker Symbol Market Type
Axsome Therapeutics Inc AXSM NASDAQ Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
5.72 8.02% 77.05 70.52 77.27 71.60 71.33 17:02:50
more quote information »

Recent News

Date Time Source Heading
7/30/202007:00GLOBEAxsome Therapeutics to Report Second Quarter 2020 Financial..
7/13/202007:06EDGARCurrent Report Filing (8-k)
7/13/202007:00GLOBEAxsome Therapeutics Completes Successful FDA Pre-NDA Meeting..
6/30/202008:21EDGARStatement of Changes in Beneficial Ownership (4)
6/30/202008:19EDGARStatement of Changes in Beneficial Ownership (4)
6/26/202007:06EDGARCurrent Report Filing (8-k)
6/26/202007:00GLOBEAxsome Therapeutics Receives FDA Breakthrough Therapy..
6/08/202006:03EDGARCurrent Report Filing (8-k)
6/05/202018:43EDGARStatement of Changes in Beneficial Ownership (4)
6/05/202018:42EDGARStatement of Changes in Beneficial Ownership (4)
6/05/202018:41EDGARStatement of Changes in Beneficial Ownership (4)
6/04/202007:00GLOBEAxsome Therapeutics to Present at Upcoming Investor..
5/29/202007:00GLOBEAxsome Therapeutics Presents Data from GEMINI Phase 3 Trial..
5/26/202007:05EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
5/26/202007:00GLOBEAxsome Therapeutics to Host 2020 Annual Meeting of..
5/11/202017:14EDGARSecurities Registration: Employee Benefit Plan (s-8)
5/11/202017:08EDGARQuarterly Report (10-q)
5/08/202016:51EDGARCurrent Report Filing (8-k)
5/08/202007:00GLOBEAxsome Therapeutics Reports First Quarter 2020 Financial..
4/30/202007:00GLOBEAxsome Therapeutics to Report First Quarter 2020 Financial..
4/27/202008:01EDGARCurrent Report Filing (8-k)
4/27/202006:00GLOBEAxsome Therapeutics Announces AXS-05 Achieves Primary..
4/21/202017:09EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/21/202017:07EDGARProxy Statement (definitive) (def 14a)
4/21/202017:05EDGARCurrent Report Filing (8-k)
4/06/202008:19EDGARCurrent Report Filing (8-k)
4/06/202006:00GLOBEAxsome Therapeutics Announces AXS-07 Achieves Both..
3/31/202008:45NNWMedical Mushroom Companies Expand as People Seek New Mental..
3/30/202009:48EDGARCurrent Report Filing (8-k)
3/30/202006:00GLOBEAxsome Therapeutics Announces Topline Results of the..
3/20/202007:06EDGARCurrent Report Filing (8-k)
3/20/202007:00GLOBEAxsome Therapeutics Accelerates Completion of the ADVANCE-1..
3/12/202017:31EDGARAnnual Report (10-k)
3/12/202016:50EDGARCurrent Report Filing (8-k)
3/12/202007:08EDGARCurrent Report Filing (8-k)
3/12/202007:00GLOBEAxsome Therapeutics Reports Fourth Quarter and Full Year..
3/09/202018:51EDGARInitial Statement of Beneficial Ownership (3)
3/06/202008:45NNWCompanies Around the World Broaden Offerings to Enhance..
3/05/202007:06EDGARCurrent Report Filing (8-k)
3/05/202007:00GLOBEAxsome Therapeutics Announces the Promotion of Mark Jacobson..
3/04/202007:00GLOBEAxsome Therapeutics to Report Fourth Quarter and Full Year..
2/20/202007:06EDGARCurrent Report Filing (8-k)
2/19/202007:00GLOBEAxsome Therapeutics to Present at Upcoming Investor..
2/14/202016:17EDGARAmended Statement of Ownership (sc 13g/a)
1/22/202007:00GLOBEAxsome Therapeutics Completes Patient Randomization in the..
1/13/202006:52DJNAxsome Inks License Pact With Pfizer on Narcolepsy,..
1/13/202006:00GLOBEAxsome Therapeutics Enters into Exclusive License Agreement..
12/30/201906:15GLOBEAxsome Therapeutics Announces AXS-07 Achieves Co-Primary and..
12/23/201916:19GLOBEAxsome Therapeutics Announces Closing of $200 Million Public..
12/19/201907:05GLOBEAxsome Therapeutics Announces Pricing of Public Offering of..
See more news about this stock »
Your Recent History
NASDAQ
AXSM
Axsome The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200804 00:26:56